摘要 |
<p>The invention relates to thrombin compositions with reduced levels of high molecular weight impurities. In particular, the levels of factor Va, prions and/or viral agents are greatly reduced. Ts invention also relates generally to methods for the preparation of thrombin having a high degree of purity and high specific activity. More specifically, the invention encompasses steps to exclude high molecular weight impurities from thrombin preparations by size exclusion filtration. In additional embodiments, the preparation of thrombin additionally includes an ion exchange filtration step. The methods of the invention are particularly suited for large scale purification of thrombin. This invention also relates generally to stabilized formulations containing thrombin cormpositions. More specifically, the present invention relates to stabilized, liquid formulations containing thrombin having a high degree of purity and high specific activity and methods of making and using such formulations.</p> |
申请人 |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC. |
发明人 |
PAWLAK, DAN;KNOLL, BRADLEY, H.;TERRAB, ABDEL HAK;CHESMORE, GERALD;IRWIN, J. FOSTER |